EU Dificlir launch means new Astellas milestones for Optimer
This article was originally published in Scrip
Executive Summary
Astellas has launched the macrocyclic antibiotic Dificlir (fidaxomicin) in Europe, triggering additional milestone payments to originator and licensor Optimer Pharmaceuticals.